223 related articles for article (PubMed ID: 33210016)
1. Baseline characteristics and age-related macular degeneration in participants of the "ASPirin in Reducing Events in the Elderly" (ASPREE)-AMD trial.
Robman LD; Phuong Thao LT; Guymer RH; Wolfe R; Woods RL; Hodgson LA; Phung J; Makeyeva GA; Le-Pham YA; Orchard SG; Suleiman J; Maguire E; Trevaks RE; Ward SA; Riaz M; Lacaze P; Storey E; Abhayaratna WP; Nelson MR; Ernst ME; Reid CM; McNeil JJ;
Contemp Clin Trials Commun; 2020 Dec; 20():100667. PubMed ID: 33210016
[TBL] [Abstract][Full Text] [Related]
2. Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical Trial.
Robman LD; Wolfe R; Woods RL; Thao LTP; Makeyeva GA; Hodgson LAB; Lepham YA; Jachno K; Phung J; Maguire E; Luong H; Trevaks RE; Ward SA; Fitzgerald SM; Orchard SG; Lacaze P; Storey E; Abhayaratna WP; Nelson MR; Guymer RH; McNeil JJ
JAMA Ophthalmol; 2024 May; ():. PubMed ID: 38780931
[TBL] [Abstract][Full Text] [Related]
3. Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study.
Robman L; Guymer R; Woods R; Ward S; Wolfe R; Phung J; Hodgson L; Makeyeva G; Aung KZ; Gilbert T; Lockery J; Le-Pham YA; Orchard S; Storey E; Abhayaratna W; Reid D; Ernst ME; Nelson M; Reid C; McNeil J
Contemp Clin Trials Commun; 2017 Jun; 6():105-114. PubMed ID: 28736754
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of self-reported age-related macular degeneration in the ASPREE Longitudinal Study of Older Persons.
McGuinness MB; Robman L; Hodgson LAB; Tran C; Woods RL; Owen AJ; McNeil JJ; Makeyeva G; Abhayaratna WP; Guymer RH
Eye (Lond); 2024 Mar; 38(4):698-706. PubMed ID: 37731049
[TBL] [Abstract][Full Text] [Related]
5. Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe: The EYE-RISK Consortium.
Colijn JM; Meester-Smoor M; Verzijden T; de Breuk A; Silva R; Merle BMJ; Cougnard-Grégoire A; Hoyng CB; Fauser S; Coolen A; Creuzot-Garcher C; Hense HW; Ueffing M; Delcourt C; den Hollander AI; Klaver CCW;
Ophthalmology; 2021 Jul; 128(7):1039-1049. PubMed ID: 33253757
[TBL] [Abstract][Full Text] [Related]
6. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
[TBL] [Abstract][Full Text] [Related]
7. A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.
van Asten F; Simmons M; Singhal A; Keenan TD; Ratnapriya R; Agrón E; Clemons TE; Swaroop A; Lu Z; Chew EY;
Ophthalmology; 2018 Apr; 125(4):559-568. PubMed ID: 29096998
[TBL] [Abstract][Full Text] [Related]
8. The Phenotypic Course of Age-Related Macular Degeneration for ARMS2/HTRA1: The EYE-RISK Consortium.
Thee EF; Colijn JM; Cougnard-Grégoire A; Meester-Smoor MA; Verzijden T; Hoyng CB; Fauser S; Hense HW; Silva R; Creuzot-Garcher C; Ueffing M; Delcourt C; den Hollander AI; Klaver CCW;
Ophthalmology; 2022 Jul; 129(7):752-764. PubMed ID: 35240203
[TBL] [Abstract][Full Text] [Related]
9. Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical Trial.
Barker AL; Morello R; Thao LTP; Seeman E; Ward SA; Sanders KM; Cumming RG; Pasco JA; Ebeling PR; Woods RL; Wolfe R; Khosla S; Hussain SM; Ronaldson K; Newman AB; Williamson JD; McNeil JJ
JAMA Intern Med; 2022 Dec; 182(12):1289-1297. PubMed ID: 36342703
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Genetic Variants Associated With Age-Related Macular Degeneration Varies With Age.
Schick T; Lorés-Motta L; Altay L; Fritsche LG; den Hollander AI; Fauser S
Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):17. PubMed ID: 33320170
[TBL] [Abstract][Full Text] [Related]
11. ARMS2 increases the risk of early and late age-related macular degeneration in the European Eye Study.
Chakravarthy U; McKay GJ; de Jong PT; Rahu M; Seland J; Soubrane G; Tomazzoli L; Topouzis F; Vingerling JR; Vioque J; Young IS; Sofat R; Hingorani AD; Fletcher AE
Ophthalmology; 2013 Feb; 120(2):342-8. PubMed ID: 23098369
[TBL] [Abstract][Full Text] [Related]
12. Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort.
Joachim N; Mitchell P; Rochtchina E; Tan AG; Wang JJ
Ophthalmology; 2014 Apr; 121(4):917-25. PubMed ID: 24332537
[TBL] [Abstract][Full Text] [Related]
13. The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study.
Joachim N; Mitchell P; Burlutsky G; Kifley A; Wang JJ
Ophthalmology; 2015 Dec; 122(12):2482-9. PubMed ID: 26383995
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in ARMS2/HTRA1 and complement genes and age-related macular degeneration in India: findings from the INDEYE study.
Sundaresan P; Vashist P; Ravindran RD; Shanker A; Nitsch D; Nonyane BA; Smeeth L; Chakravarthy U; Fletcher AE
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7492-7. PubMed ID: 23060141
[TBL] [Abstract][Full Text] [Related]
15. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
[TBL] [Abstract][Full Text] [Related]
16. Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Myers CE; Meuer SM; Gangnon RE; Sivakumaran TA; Iyengar SK; Lee KE; Klein BE
JAMA Ophthalmol; 2013 Mar; 131(3):383-92. PubMed ID: 23494043
[TBL] [Abstract][Full Text] [Related]
17. Association Between Perifoveal Drusen Burden Determined by OCT and Genetic Risk in Early and Intermediate Age-Related Macular Degeneration.
Seddon JM; Dossett JP; Widjajahakim R; Rosner B
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4469-4478. PubMed ID: 31658355
[TBL] [Abstract][Full Text] [Related]
18. The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20.
Keenan TD; Wiley HE; Agrón E; Aronow ME; Christen WG; Clemons TE; Chew EY;
Ophthalmology; 2019 Dec; 126(12):1647-1656. PubMed ID: 31358390
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
Domalpally A; Agrón E; Pak JW; Keenan TD; Ferris FL; Clemons TE; Chew EY
Ophthalmology; 2019 Dec; 126(12):1659-1666. PubMed ID: 31558345
[TBL] [Abstract][Full Text] [Related]
20. Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study.
McNeil JJ; Woods RL; Nelson MR; Murray AM; Reid CM; Kirpach B; Storey E; Shah RC; Wolfe RS; Tonkin AM; Newman AB; Williamson JD; Lockery JE; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Trevaks RE; Orchard SG; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Grimm RH;
J Gerontol A Biol Sci Med Sci; 2017 Oct; 72(11):1586-1593. PubMed ID: 28329340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
